M&T Bank Corp Becton Dickinson & CO Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Becton Dickinson & CO stock. As of the latest transaction made, M&T Bank Corp holds 52,106 shares of BDX stock, worth $12.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

52,106

Previous 52,724 1.17%

Holding current value

$12.6 Million

Previous $13 Million 6.66%

% of portfolio

0.04%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$225.07 - $246.17 $139,093 - $152,133	-618 Reduced 1.17%	52,106 $12.2 Million
Q1 2024 May 07, 2024	SELL	$233.45 - $247.73 $330,098 - $350,290	-1,414 Reduced 2.61%	52,724 $13 Million
Q4 2023 Feb 06, 2024	SELL	$232.24 - $267.23 $6.43 Million - $7.4 Million	-27,685 Reduced 33.84%	54,138 $13.2 Million
Q3 2023 Nov 02, 2023	SELL	$254.9 - $283.59 $77,489 - $86,211	-304 Reduced 0.37%	81,823 $21.2 Million
Q2 2023 Aug 09, 2023	BUY	$238.39 - $265.32 $93,448 - $104,005	392 Added 0.48%	82,127 $21.7 Million
Q1 2023 May 11, 2023	BUY	$229.71 - $259.35 $550,614 - $621,661	2,397 Added 3.02%	81,735 $20.2 Million
Q4 2022 Feb 13, 2023	BUY	$218.29 - $256.91 $2.14 Million - $2.52 Million	9,821 Added 12.89%	86,004 $21.9 Million
Q4 2022 Feb 13, 2023	SELL	$218.29 - $256.91 $1.46 Million - $1.71 Million	-6,666 Reduced 7.75%	79,338 $20.2 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $106,703 - $552,504	-2,091 Reduced 2.67%	76,183 $17 Million
Q2 2022 Aug 05, 2022	BUY	$234.74 - $275.42 $642,483 - $753,824	2,737 Added 3.62%	78,274 $18.8 Million
Q1 2022 May 09, 2022	BUY	$243.64 - $270.48 $2.9 Million - $3.22 Million	11,895 Added 18.69%	75,537 $20.1 Million
Q4 2021 Feb 07, 2022	SELL	$230.08 - $250.94 $847,384 - $924,212	-3,683 Reduced 5.47%	63,642 $16 Million
Q3 2021 Oct 28, 2021	SELL	$232.72 - $256.47 $402,838 - $443,949	-1,731 Reduced 2.51%	67,325 $16.5 Million
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $498,568 - $545,564	-2,143 Reduced 3.01%	69,056 $16.8 Million
Q1 2021 May 06, 2021	SELL	$232.09 - $256.88 $992,416 - $1.1 Million	-4,276 Reduced 5.67%	71,199 $17.3 Million
Q4 2020 Feb 12, 2021	SELL	$221.92 - $245.94 $357,291 - $395,963	-1,610 Reduced 2.09%	75,475 $18.9 Million
Q3 2020 Nov 06, 2020	SELL	$215.77 - $276.76 $67,536 - $86,625	-313 Reduced 0.4%	77,085 $17.9 Million
Q2 2020 Jul 29, 2020	SELL	$219.9 - $263.41 $1.09 Million - $1.3 Million	-4,942 Reduced 6.0%	77,398 $18.5 Million
Q1 2020 May 14, 2020	SELL	$195.69 - $279.01 $158,900 - $226,556	-812 Reduced 0.98%	82,340 $18.9 Million
Q4 2019 Feb 07, 2020	SELL	$236.45 - $266.82 $701,074 - $791,121	-2,965 Reduced 3.44%	83,152 $22.6 Million
Q3 2019 Nov 12, 2019	SELL	$230.58 - $256.08 $591,437 - $656,845	-2,565 Reduced 2.89%	86,117 $21.8 Million
Q2 2019 Aug 12, 2019	BUY	$217.4 - $246.08 $793,727 - $898,438	3,651 Added 4.29%	88,682 $22.4 Million
Q1 2019 May 15, 2019	SELL	$206.05 - $248.17 $26,992 - $32,510	-131 Reduced 0.15%	85,031 $21.2 Million
Q4 2018 Feb 01, 2019	SELL	$204.73 - $257.93 $344,560 - $434,096	-1,683 Reduced 1.94%	85,162 $19.2 Million
Q3 2018 Nov 09, 2018	SELL	$233.07 - $256.0 $1.08 Million - $1.19 Million	-4,643 Reduced 5.07%	86,845 $22.7 Million
Q2 2018 Aug 10, 2018	SELL	$208.1 - $233.85 $7,491 - $8,418	-36 Reduced 0.04%	91,488 $21.9 Million
Q1 2018 May 04, 2018	BUY	$205.46 - $240.27 $5.71 Million - $6.67 Million	27,771 Added 43.56%	91,524 $19.8 Million
Q4 2017 Feb 06, 2018	BUY	$189.0 - $222.64 $196,749 - $231,768	1,041 Added 1.66%	63,753 $13.6 Million
Q3 2017 Nov 13, 2017	SELL	$186.89 - $198.9 $73,260 - $77,968	-392 Reduced 0.62%	62,712 $12.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	63,104	63,104 $12.3 Million

Others Institutions Holding BDX

# of Institutions

1,733

Shares Held

252M

Call Options Held

586K

Put Options Held

649K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $68.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account